Selective Covalent Targeting of Anti‐apoptotic BFL‐1 by a Sulfonium‐Tethered Peptide
Citations Over TimeTop 21% of 2020 papers
Abstract
Anti-apoptotic B cell lymphoma 2 (BCL-2) family proteins are proven targets for human cancers. Targeting the BH3-binding pockets of these anti-apoptotic proteins could reactivate apoptosis in BCL-2-depedent cancers. BFL-1 is a BCL-2 family protein overexpressed in various chemoresistant cancers. A unique cysteine at the binding interface of the BH3 and BFL-1 was previously proven to be an intriguing targeting site to irreversibly inhibit BFL-1 functions with stabilized cyclic peptide bearing a covalent warhead. Recently, we developed a sulfonium-tethered peptide cyclization strategy to construct peptide ligands that could selectively and efficiently react with the cysteine(s) of target proteins near the interacting interface. Using this method, we constructed a BFL-1 peptide inhibitor, B4-MC, that could selectively conjugate with BFL-1 both in vitro and in cell. B4-MC showed good cellular uptake, colocalized with BFL-1 on mitochondria, and showed obvious growth inhibition of BFL-1 over-expressed cancer cell lines.
Related Papers
- → Radical C−C Bond Formation using Sulfonium Salts and Light(2020)204 cited
- → Synthesis of SCF3‐Substituted Sulfonium Ylides from Sulfonium Salts or α‐Bromoacetic Esters(2021)3 cited
- → Electroorganic chemistry—XV(1973)15 cited
- → MULTIPLE PATHWAYS IN THE BASE-CATALYZED REACTIONS OFS-ALLYL SULFONIUM COMPOUNDS(1976)1 cited
- → ChemInform Abstract: Sulfonium Salts and Sulfonium Ylides of Pyrazoles.(1990)